Simultaneous quantification of daptomycin and rifampicin in plasma by ultra performance liquid chromatography: Application to a pharmacokinetic study

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 4, 2010, Pages 901-906

  Gikas, Evangelos ^a   Bazoti, Fotini N ^a   Fanourgiakis, Panagiotis ^b   Perivolioti, Efstathia ^b   Roussidis, Andreas ^c   Skoutelis, Athanasios ^b   Tsarbopoulos, Anthony ^a,c  

^a Goulandris Natural History Museum   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Daptomycin; Plasma; Rifampicin; Ultra performance liquid chromatography

Indexed keywords

4 NITROPHENOL; ACETONITRILE; DAPTOMYCIN; METHANOL; RIFAMPICIN; UNCLASSIFIED DRUG; VETRANAL;

ACCURACY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG STRUCTURE; ELUTION; LIQUID CHROMATOGRAPHY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; RABBIT; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION PROCESS;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, LIQUID; DAPTOMYCIN; INJECTIONS, INTRAVENOUS; OBSERVER VARIATION; RABBITS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RIFAMPIN; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 72449171923     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.10.013     Document Type: Article

References (15)

1. Arias C.A., and Murray B.E. Emergence and management of drug-resistant enterococcal infections. Expert Rev. Anti-Infect. Ther. 6 (2008) 637-655
2. Steenbergen J.N., Alder J., Thorne G.M., and Tally F.P. Daptomycin: a lipopeptide antibiotic for the treatment of serious gram-positive infections. J. Antimicrob. Chemother. 55 (2005) 283-288
3. Jacobson L.M., Milstone A.M., Zenilman J., Carroll K.C., and Arav-Boger R. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. Pediatr. Infect. Dis. J. 28 (2009) 445-447
4. Dvorchik B.H., Brazier D., DeBruin M.F., and Arbeit R.D. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob. Agents Chemother. 47 (2003) 1318-1323
5. Nguyen H.A., Denis O., Vergison A., Tulkens P.M., Struelens M.J., and Van Bambeke F. Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: study of antibiotic combinations. Antimicrob. Agents Chemother. 53 (2009) 1443-1449
6. Warren R.E. Daptomycin in endocarditis and bacteraemia: a British perspective. J. Antimicrob. Chemother. 62 Suppl. 3 (2008) iii 25-33
7. Rand K.H., and Houck H. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. J. Antimicrob. Chemother. 53 (2004) 530-532
8. Hartkoorn R.C., Khoo S., Back D.J., Tjia J.F., Waitt C.J., Chaponda M., Davies G., Ardrey A., Ashleigh S., and Ward S.A. A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 857 (2007) 76-82
9. Allanson A.L., Cotton M.M., Tettey J.N.A., and Boyter A.C. Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection: a potential method for therapeutic drug monitoring. J. Pharm. Biomed. Anal. 44 (2007) 963-969
10. Swart K.J., and Papgis M.J. Automated high-performance liquid chromatographic method for the determination of rifampicin in plasma. J. Chromatogr. 593 (1992) 21-24
11. Calleja M.J., Blanco-Prieto N., Ruz M.J., Renedo M.C., and Dios-Vieitez. High-performance liquid-chromatographic determination of rifampicin in plasma and tissues. J. Chromatogr. A 1031 (2004) 289-294
12. Tobin C.M., Darville J.M., Lovering A.M., and Macgowan A.P. An HPLC assay for daptomycin in serum. J. Antimicrob. Chemother. 62 (2008) 1462-1463
13. Martens-Lobenhoffer J., Kielstein J.T., Oye C., and Bode-Böger S.M. Validated high performance liquid chromatography-UV detection method for the determination of daptomycin in human plasma. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 875 (2008) 546-550
14. Dandekar P.K., Tessier P.R., Williams P., Nightingale C.H., and Nicolau D.P. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model. J. Antimicrob. Chemother. 52 (2003) 405-411
15. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May 2001 BP, http://www.fda.gov/cder/guidance/indes.htm.